Susquehanna International Group
CLSD

Susquehanna International Group’s Clearside Biomedical CLSD Stock Holding History

Susquehanna International Group’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-700
Closed -$9.66K – 12758
2025
Q1 		$9.66K Buy
+700
New +$10.1K ﹤0.01% 12215
2024
Q4 		– Sell
-960
Closed -$18.3K – 12296
2024
Q3 		$18.3K Buy
+960
New +$16.4K ﹤0.01% 11645
2023
Q4 		– Sell
-4,287
Closed -$55.9K – 12441
2023
Q3 		$55.9K Sell
4,287
-360
-8% -$5.45K ﹤0.01% 11247
2023
Q2 		$78.1K Buy
4,647
+567
+14% +$9.76K ﹤0.01% 11120
2023
Q1 		$63.6K Buy
4,080
+2,660
+187% +$51.7K ﹤0.01% 11583
2022
Q4 		$23.9K Sell
1,420
-8,247
-85% -$149K ﹤0.01% 11698
2022
Q3 		$164K Sell
9,667
-826
-8% -$18.1K ﹤0.01% 11118
2022
Q2 		$231K Buy
10,493
+520
+5% +$12.6K ﹤0.01% 10265
2022
Q1 		$343K Sell
9,973
-13,794
-58% -$413K ﹤0.01% 9932
2021
Q4 		$980K Sell
23,767
-1,240
-5% -$80.3K ﹤0.01% 7353
2021
Q3 		$2.25M Buy
25,007
+14,534
+139% +$1.28M ﹤0.01% 5576
2021
Q2 		$765K Buy
10,473
+946
+10% +$44K ﹤0.01% 8500
2021
Q1 		$353K Buy
+9,527
New +$478K ﹤0.01% 10267
2020
Q3 		– Sell
-7,447
Closed -$210K – 10584
2020
Q2 		$210K Sell
7,447
-13,820
-65% -$407K ﹤0.01% 8955
2020
Q1 		$542K Buy
21,267
+13,574
+176% +$502K ﹤0.01% 6758
2019
Q4 		$335K Buy
+7,693
New +$162K ﹤0.01% 7807
2018
Q4 		– Sell
-5,880
Closed -$542K – 9025
2018
Q3 		$542K Buy
5,880
+1,787
+44% +$212K ﹤0.01% 6362
2018
Q2 		$656K Buy
4,093
+2,826
+223% +$476K ﹤0.01% 6264
2018
Q1 		$204K Buy
+1,267
New +$154K ﹤0.01% 8291

Other funds holding CLSD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group's CLSD Position: Q3 2025 in Review

Susquehanna International Group sold out of Clearside Biomedical (CLSD) in Q3 2025, closing a stake of 5,975 shares — an estimated $71.7K sold.

Susquehanna International Group first reported a position in CLSD in Q4 2016 and held it in 23 quarters. The position peaked at $2.26M in Q3 2021. 26 funds tracked by Wall St. Rank hold CLSD as of Q3 2025.

  • Susquehanna International Group reported no remaining Clearside Biomedical position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 5,975 Clearside Biomedical shares in Q3 2025, an estimated $71.7K.
  • Susquehanna International Group first reported a position in Clearside Biomedical in Q4 2016 and held it in 23 quarters.
  • Susquehanna International Group's Clearside Biomedical position peaked at $2.26M in Q3 2021.
  • 26 funds tracked by Wall St. Rank held Clearside Biomedical as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.